Drug Trial Radar · NCT05255991
Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
597
Actual
Start
Sep 12, 2022
Primary completion
Jun 30, 2025
Study completion Jun 30, 2025
Sponsor
- Lead sponsor
- United TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study RIN-PF-303 is a multinational study designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
Conditions
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
Interventions
PlaceboDrug
Placebo administered QID
Inhaled TreprostinilDrug
Inhaled treprostinil (6 mcg/breath) administered QID
Treprostinil Ultrasonic NebulizerDevice
Treprostinil ultrasonic nebulizer which emits a dose of approximately 6 mcg per breath.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Absolute FVC From Baseline to Week 52Time frame: Baseline to Week 52
Locations
108 sites in 16 countries. Site status is shown where the registry gives one.
CINME S.A. - Centro de Investigaciones Metabolicas
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Centro Medico Dra. De Salvo
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Instituto Ave Pulmo - Fundación enfisema
Mar del Plata, Buenos Aires, Argentina
Sanatorio Allende S.A.
Córdoba, Córdoba Province, Argentina
Instituto Médico Río Cuarto
Río Cuarto, Córdoba Province, Argentina
Centro Médico INSARES
Mendoza, Mendoza Province, Argentina
Sanatorio Parque - Consultorios Externos
Rosario, Santa Fe Province, Argentina
Centro Integral de Medicina Respiratoria
San Miguel de Tucumán, Tucumán Province, Argentina
Investigaciones en Patologías Respiratorias
San Miguel de Tucumán, Tucumán Province, Argentina
Royal Prince Alfred Hospital, Missenden Road
Camperdown, New South Wales, Australia
Macquarie University
Macquarie Park, New South Wales, Australia
Westmead Hospital, Corner of Hawkesbury and Darcy Road
Westmead, New South Wales, Australia
Cairns Hospital
Cairns, Queensland, Australia
Lung Research Qld
Chermside, Queensland, Australia
Prince Charles Hospital
Chermside, Queensland, Australia
Mater Misericordiae Ltd
South Brisbane, Queensland, Australia
Respiratory Clinical Trials Pty Ltd
Kent Town, South Australia, Australia
Alfred Health
Melbourne, Victoria, Australia
Austin Health
Melbourne, Victoria, Australia
Institute for Respiratory Health - Midland
Nedlands, Western Australia, Australia
Institute for Respiratory Health - Nedlands
Nedlands, Western Australia, Australia
AZORG vzw
Aalst, Belgium
Ziekenhuis Aan de Stroom
Antwerp, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
UZ Leuven
Leuven, Belgium
CHR de la Citadelle
Liège, Belgium
CHU de Liège
Liège, Belgium
Hôpital Erasme
Anderlecht, Brussels Capital, Belgium
CHU UCL Namur asbl - Site Godinne
Yvoir, Namur, Belgium
Centro de Investigacion del Maule SpA
Talca, Maule Region, Chile
Instituto Nacional Torax
Santiago, Santiago Metropolitan, Chile
Fundación Médica San Cristobal
Santiago, Santiago Metropolitan, Chile
Oncocentro APYS
Viña del Mar, Valparaiso, Chile
Aarhus University Hospital - Department of Respiratory Diseases and Allergy, Research Unit
Aarhus N, Denmark
Gentofte Hospital - Lungemedicinsk forskning
Hellerup, Denmark
Odense University Hospital - Department of Respiratory Medicine J.
Odense C, Denmark
CHU Amiens Picardie Site Sud - Service de Pneumologie
Amiens, France
Hopital Cote de Nacre
Caen, France
Groupement Hospitalier EST, Service de Pneumologie
Lyon, France
APHM-Hôpital Nord
Marseille, France
Showing 40 of 108 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.